Asphalion is excited to announce the forthcoming events on FDA Regulatory Affairs.
Presented jointly with our US agent Bruce Thompson of REGULIANCE, the open seminars will provide a thorough understanding of US regulatory activities.
Save the dates!
- 23rd January 2018, Munich (Germany) – FDA Regulatory Affairs during Drug Development
In cooperation with BioM Biotech Cluster Development, Asphalion and Reguliance will run a practical workshop that will offer an in-depth look into US FDA Regulatory Affairs, focusing on real-life situations of European drug development companies. Latest political changes in the US and their practical implications will be discussed as part of the general overview of how FDA operates and what rules apply for the development of human medicines.
- 7-8th June 2018, Barcelona (Spain) – FDA Open Seminar: Opportunities Ahead
The 5th edition of our FDA Open Seminar will provide a structured introduction to all important aspects of FDA regulatory affairs. From setting the initial strategy, preparing and submitting regulatory dossiers, up to successful marketing authorization in the USA, the sessions will be distributed in two days.
Give us your contact data and we will keep you informed on the FDA upcoming events organized by Asphalion. Register here to know all the details!
We are pleased to invite you to join the seminars to refresh or to start your FDA knowledge and expertise! Our experts will share their practical experience of many years of dealing with FDA submissions.
Do not miss it! We look forward meeting you!
Do not hesitate to contact us for further information at openseminar@asphalion.com
